Please upgrade your browser.
During Kidney Cancer Awareness Month, the Kidney Cancer Association highlights some of the many effective collaborations it has formed with other cancer organizations.
The chance of contracting renal cell carcinoma, a common type of kidney cancer, can be reduced to a great extent by including cod fish in the diet.
Small kidney tumours have an agressive potential and should be treated, according to a the results of a large multicentre study presented at the 28th Annual EAU Congress in Milan.
IL-11 and its receptor, IL-11Ra, are expressed in human cancers; however, the functional role of IL-11 in tumor progression is not known. We found that IL11 is a hypoxia-inducible, VHL-regulated gene in human cancer cells and that expression of IL11 mRNA was dependent, at least in part, on HIF-1.
The annual report contains plenty of good news concerning funding for kidney cancer research projects.
The purpose of this study is to assess the safety and tolerability of BMS-986015 given in combination with BMS-936558...
Tivozanib is an oral inhibitor of vascular endothelial growth factor (VEGF), and inhibits all three VEGF receptors. AVEO Pharmaceuticals (AVEO) submitted an NDA in September 2012, based on results of the global Phase III TIVO-1 trial, a randomized superiority-designed pivotal trial evaluating the efficacy and safety of tivozanib compared to sorafenib (Nexavar®) in 517 patients with advanced renal cell carcinoma ((RCC)) who had no prior treatment with a systemic therapy, as well as data from 17 clinical studies involving over 1,000 subjects who received tivozanib.
The 2013 Genitourinary Cancers Symposium, held February 14-16, 2013, in Orlando, Florida, focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of genitourinary (GU) cancers.
Under the proposals, Barnet patients may have to go to the Royal Free Hospital, in Hampstead, or University College Hospital, in Bloomsbury, central London, for surgery.
Pikul’s husband, Frank, was diagnosed with kidney cancer in 2010. Since that time, he participated in a clinical trial at Memorial Sloan-Kettering Cancer Center in New York, underwent surgery and treatment, and is now doing well. The experience prompted Erin to create the Renal Race as a way to support the research and advocacy of the Kidney Cancer Association.
|Powered by NeonCRM|